Stallion India Fluorochemicals Reports Strong Half-Year Growth, Details IPO Fund Utilization
Stallion India Fluorochemicals reported strong half-year financial results with increased revenue and profit, alongside details on the utilization of IPO proceeds for working capital and capital expenditures.
The announcement provides crucial financial performance data showing significant half-year growth and details the deployment of substantial IPO capital for key strategic initiatives. This information is vital for investor assessment of the company's financial health and future growth prospects.
The company demonstrated strong year-on-year growth in revenue and profit for the half-year ended September 30, 2025. Additionally, the ongoing utilization of IPO funds for strategic projects like capital expenditure indicates positive operational and growth momentum.
* Stallion India Fluorochemicals Limited announced its unaudited financial results for the quarter and half year ended September 30, 2025. * For the half year ended September 30, 2025, the company reported revenue from operations of ₹1,764.86 lakh and a total income of ₹1,782.56 lakh. The profit for the period stood at ₹169.48 lakh. * For the quarter ended September 30, 2025, revenue from operations was ₹1,055.41 lakh, total income was ₹1,065.74 lakh, and profit for the period was ₹67.17 lakh. * The company also provided an update on the utilization of net IPO proceeds totaling ₹14,873.95 lakh (net of IPO expenses of ₹1,198.92 lakh). * Utilization as of September 30, 2025, includes: * Funding incremental working capital requirements: ₹57.00 lakh utilized out of ₹500.00 lakh allocated. * Funding capital expenditure for Semi-conductor & Specialty Gas facility at Khalapur, Maharashtra: ₹138.07 lakh utilized out of ₹291.54 lakh allocated. * Funding capital expenditure for Refrigerant facility at Mambattu, Andhra Pradesh: ₹19.96 lakh utilized out of ₹211.75 lakh allocated. * General Corporate Purposes: ₹34.08 lakh utilized out of ₹34.08 lakh allocated. * Unutilized IPO proceeds as of September 30, 2025, were temporarily invested in fixed deposits with banks, monitoring agency bank accounts, IPO public issue accounts, and the company's current account.
What to do with a filing like this
Stallion India Fluorochemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Stallion India Fluorochemicals Limited. Read the original for the full detail.